Patent · US Active

5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative

US10273249B2 · kind B2 · utility

0Cited by

2References

5Claims

0Family size

Assignee

PULMOCIDE LIMITED · GB

Inventors

Simon Fraser Hunt · London, GB
Stuart Thomas Onions · Nottingham, GB
Vladimir Sherbukhin · Nottingham, GB
Euan Alexander Fraser Fordyce · Nottingham, GB
Peter John Murray · London, GB
Daniel William Brookes · London, GB
Kazuhiro Ito · London, GB
Peter Strong · London, GB
Matthew Stephen Coates · London, GB

Key dates

Filing date	Jul 12, 2018
Grant date	Apr 30, 2019
Priority date	—
Expiry date	Jul 12, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided a 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative which is useful in the treatment of respiratory syncytial virus (RSV) infection and for the prevention of disease associated with RSV infection. (Formula (1)).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.